Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy

Rationale: Photodynamic therapy (PDT) is a clinically approved anticancer treatment with a promising therapeutic prospect, however, usually suffers from the unfavorable intracellular environment including cellular hypoxia and excessive glutathione (GSH). Comprehensive and long-term modulation of tum...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang, Zuo, Qiao, Chaoqiang, Jia, Qian, Chen, Zhuang, Wang, Xiaofei, Liu, Xuelan, Zhang, Ruili, Pu, Kanyi, Wang, Zhongliang
Other Authors: School of Chemical and Biomedical Engineering
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/168617
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-168617
record_format dspace
spelling sg-ntu-dr.10356-1686172023-12-29T06:45:23Z Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy Yang, Zuo Qiao, Chaoqiang Jia, Qian Chen, Zhuang Wang, Xiaofei Liu, Xuelan Zhang, Ruili Pu, Kanyi Wang, Zhongliang School of Chemical and Biomedical Engineering Engineering::Chemical engineering Photodynamic Therapy Metal-Organic Framework Rationale: Photodynamic therapy (PDT) is a clinically approved anticancer treatment with a promising therapeutic prospect, however, usually suffers from the unfavorable intracellular environment including cellular hypoxia and excessive glutathione (GSH). Comprehensive and long-term modulation of tumor intracellular environment is crucial for optimizing therapeutic outcomes. However, current strategies do not enable such requirements, mainly limited by flexible networks of intracellular metabolic avenues. Methods: A metabolic pre-intervention (MPI) strategy that targets critical pathways of cellular metabolism, ensuring long-term modulation of the intracellular environment. A versatile lipid-coating photosensitive metal-organic framework (MOF) nano-vehicle encapsulating aerobic respiration inhibitor metformin (Met) and GSH biosynthesis inhibitor buthionine sulfoximine (BSO) (termed PBMLR) was developed for comprehensive sustainable hypoxia alleviation and GSH downregulating. Results: Since MPI could effectively circumvent the compensatory accessory pathway, PBMLR, therefore functioned as an efficient singlet oxygen (1O2) radical generator during the subsequent laser irradiation process and enhanced PDT anti-tumor efficiency. We emphasized the concordance of long-term hypoxia alleviation, persistent GSH depletion, and tumor enrichment of photosensitizers, which is very meaningful for a broad therapeutic time window and the successful enhancement of PDT. Conclusion: Our findings indicate that maintaining the sensitivity of tumor cells via MPI could enhance anti-tumor PDT, and may be applied to other dynamic therapies such as radiodynamic therapy and sonodynamic therapy. Published version This work was supported by the National Key Research and Development Program of China (Nos. 2017YFC1309100 and 2017YFA0205200), National Natural Science Foundation of China (Nos. 21804104, 91959124, 81671753, and 32071406), Innovation Capability Support Program of Shaanxi (Program No. 2022TD-52), Natural Science Foundation of Shaanx Province of China (No. 2020PT-020), The Youth Innovation Team of Shaanxi Universities, Natural Science Basic Research Plan in Shaanxi Province of China (Nos. 2021JM-147 and 2021JQ-212), China Postdoctoral Science Foundation (No. 2022TQ0249), the Fundamental Research Funds for the Central Universities (Nos. JB211201, JB211202, JB211204, QTZX22068). 2023-06-12T05:12:34Z 2023-06-12T05:12:34Z 2022 Journal Article Yang, Z., Qiao, C., Jia, Q., Chen, Z., Wang, X., Liu, X., Zhang, R., Pu, K. & Wang, Z. (2022). Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy. Theranostics, 12(14), 6143-6154. https://dx.doi.org/10.7150/thno.75837 1838-7640 https://hdl.handle.net/10356/168617 10.7150/thno.75837 36168617 2-s2.0-85137885367 14 12 6143 6154 en Theranostics © 2022 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Engineering::Chemical engineering
Photodynamic Therapy
Metal-Organic Framework
spellingShingle Engineering::Chemical engineering
Photodynamic Therapy
Metal-Organic Framework
Yang, Zuo
Qiao, Chaoqiang
Jia, Qian
Chen, Zhuang
Wang, Xiaofei
Liu, Xuelan
Zhang, Ruili
Pu, Kanyi
Wang, Zhongliang
Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy
description Rationale: Photodynamic therapy (PDT) is a clinically approved anticancer treatment with a promising therapeutic prospect, however, usually suffers from the unfavorable intracellular environment including cellular hypoxia and excessive glutathione (GSH). Comprehensive and long-term modulation of tumor intracellular environment is crucial for optimizing therapeutic outcomes. However, current strategies do not enable such requirements, mainly limited by flexible networks of intracellular metabolic avenues. Methods: A metabolic pre-intervention (MPI) strategy that targets critical pathways of cellular metabolism, ensuring long-term modulation of the intracellular environment. A versatile lipid-coating photosensitive metal-organic framework (MOF) nano-vehicle encapsulating aerobic respiration inhibitor metformin (Met) and GSH biosynthesis inhibitor buthionine sulfoximine (BSO) (termed PBMLR) was developed for comprehensive sustainable hypoxia alleviation and GSH downregulating. Results: Since MPI could effectively circumvent the compensatory accessory pathway, PBMLR, therefore functioned as an efficient singlet oxygen (1O2) radical generator during the subsequent laser irradiation process and enhanced PDT anti-tumor efficiency. We emphasized the concordance of long-term hypoxia alleviation, persistent GSH depletion, and tumor enrichment of photosensitizers, which is very meaningful for a broad therapeutic time window and the successful enhancement of PDT. Conclusion: Our findings indicate that maintaining the sensitivity of tumor cells via MPI could enhance anti-tumor PDT, and may be applied to other dynamic therapies such as radiodynamic therapy and sonodynamic therapy.
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Yang, Zuo
Qiao, Chaoqiang
Jia, Qian
Chen, Zhuang
Wang, Xiaofei
Liu, Xuelan
Zhang, Ruili
Pu, Kanyi
Wang, Zhongliang
format Article
author Yang, Zuo
Qiao, Chaoqiang
Jia, Qian
Chen, Zhuang
Wang, Xiaofei
Liu, Xuelan
Zhang, Ruili
Pu, Kanyi
Wang, Zhongliang
author_sort Yang, Zuo
title Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy
title_short Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy
title_full Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy
title_fullStr Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy
title_full_unstemmed Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy
title_sort redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy
publishDate 2023
url https://hdl.handle.net/10356/168617
_version_ 1787136416089636864